Evercore ISI Group analyst Liisa Bayko upgrades Akero Therapeutics (NASDAQ:AKRO) from In-Line to Outperform and raises the price target from $10 to $50.
Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.
Telsey Advisory Group analyst Dana Telsey maintains American Eagle Outfitters (NYSE:AEO) with a Market Perform and lowers the price target from $17 to $15.